AI assistant
BELDEN INC. — Director's Dealing 2017
Oct 10, 2017
31053_dirs_2017-10-10_21cdd048-8a62-4cac-8e03-87ecc6db718d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BELDEN INC. (BDC)
CIK: 0000913142
Period of Report: 2017-10-06
Reporting Person: Stroup John S (Director, Chairman, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-10-06 | Common Stock | S | 10000 | $84.70 | Disposed | 21713 | Direct |
| 2017-10-06 | Common Stock | M | 34147 | $50.01 | Acquired | 55860 | Direct |
| 2017-10-06 | Common Stock | D | 26920 | $84.28 | Disposed | 28940 | Direct |
| 2017-10-09 | Common Stock | S | 7227 | $84.8212 | Disposed | 21713 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-10-06 | Stock Appreciation Rights | $50.01 | M | 34147 | Disposed | 2023-03-04 | Common Stock (34147) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4063 | Indirect |
| Common Stock | 86555 | Indirect |
Footnotes
F1: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Stroup on August 18, 2016.
F2: The exercise reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Stroup on August 18, 2016.
F3: This represents the difference between the number of SARs exercised (34,147) and the number of shares issued as a result of the exercise (7,227). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($84.28) and the exercise price ($50.01). Additional shares are then withheld to satisfy the Company's tax withholding obligations.
F4: This price represents the average sale price for multiple transactions on this line. The prices of the transactions reported on this line ranged from $84.41 to $85.57. Upon request by the SEC staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares and prices at which transactions were effected.
F5: From the original grant of 74,147 SARs, 24,716 became exercisable on March 4, 2014, 24,716 became exercisable on March 4, 2015 and 24,715 became exercisable on March 4, 2016.